Activation of immune response
- ACTB: actin, beta
- ACTG1: actin, gamma 1
- BTK: Bruton agammaglobulinemia tyrosine kinase
- C3: complement component 3
- CFH: complement factor H
- CFHR5: complement factor H-related 5
- CFI: complement factor I
- CYLD: cylindromatosis (turban tumor syndrome)
- FOXP3: forkhead box P3
- HLA-DQA1: major histocompatibility complex, class II, DQ alpha 1
- HLA-DQB1: major histocompatibility complex, class II, DQ beta 1
- HLA-DRB1: major histocompatibility complex, class II, DR beta 1
- IKBKG: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
- IRAK4: interleukin-1 receptor-associated kinase 4
- KRT1: keratin 1
- LIMK1: LIM domain kinase 1
- MAP2K1: mitogen-activated protein kinase kinase 1
- MAP2K2: mitogen-activated protein kinase kinase 2
- MBL2: mannose-binding lectin (protein C) 2, soluble
- NOD2: nucleotide-binding oligomerization domain containing 2
- PLA2G6: phospholipase A2, group VI (cytosolic, calcium-independent)
- PRNP: prion protein
- PROS1: protein S (alpha)
- PTEN: phosphatase and tensin homolog
- PTPN22: protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
- RPS6KA3: ribosomal protein S6 kinase, 90kDa, polypeptide 3
- SERPING1: serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
- WAS: Wiskott-Aldrich syndrome
- XIAP: X-linked inhibitor of apoptosis
- ZAP70: zeta-chain (TCR) associated protein kinase 70kDa
Source: Gene Ontology Consortium
.